カテゴリー： GlobalInfoResearch, 世界

SGLT2阻害剤の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）

【英語タイトル】Global SGLT2 Inhibitor Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料（GIR9101275）・商品コード：GIR9101275
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2019年9月10日（※2024年版があります。お問い合わせください）
・ページ数：115
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、SGLT2阻害剤の世界市場について調べ、まとめました。種類別セグメントは、ダパグリフロジン、カナグリフロジン、エンパグリフロジン、その他等、用途別セグメントは、病院薬局、小売薬局等に区分しました。SGLT2阻害剤の世界市場概観、メーカー動向、メーカー別SGLT2阻害剤シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・SGLT2阻害剤の市場概観
・SGLT2阻害剤の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・SGLT2阻害剤の企業別販売動向、市場シェア、市場集中度、競争動向
・SGLT2阻害剤の世界市場規模
・SGLT2阻害剤の北米市場分析（アメリカ、カナダ、メキシコ等）
・SGLT2阻害剤のアメリカ市場規模推移
・SGLT2阻害剤のカナダ市場規模推移
・SGLT2阻害剤のメキシコ市場規模推移
・SGLT2阻害剤のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・SGLT2阻害剤のドイツ市場規模推移
・SGLT2阻害剤のイギリス市場規模推移
・SGLT2阻害剤のロシア市場規模推移
・SGLT2阻害剤のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・SGLT2阻害剤の日本市場規模推移
・SGLT2阻害剤の中国市場規模推移
・SGLT2阻害剤の韓国市場規模推移
・SGLT2阻害剤のインド市場規模推移
・SGLT2阻害剤の東南アジア市場規模推移
・SGLT2阻害剤の南米市場分析（ブラジル、アルゼンチン等）
・SGLT2阻害剤の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・SGLT2阻害剤の種類別分析/販売量、売上、市場シェア（ダパグリフロジン、カナグリフロジン、エンパグリフロジン、その他）
・SGLT2阻害剤の用途別分析/市場規模（病院薬局、小売薬局）
・SGLT2阻害剤の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・SGLT2阻害剤の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Scope of the Report:
The worldwide market for SGLT2 Inhibitor is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the SGLT2 Inhibitor in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Eli Lilly
Boehringer Ingelheim
Johnson & Johnson
AstraZeneca
Merck
Pfizer

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Dapagliflozin
Canagliflozin
Empagliflozin
Other

Market Segment by Applications, can be divided into
Hospital Pharmacies
Retail Pharmacies

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe SGLT2 Inhibitor product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of SGLT2 Inhibitor, with price, sales, revenue and global market share of SGLT2 Inhibitor in 2017 and 2018.
Chapter 3, the SGLT2 Inhibitor competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the SGLT2 Inhibitor breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, SGLT2 Inhibitor market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe SGLT2 Inhibitor sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

Table of Contents

1 Market Overview
1.1 SGLT2 Inhibitor Introduction
1.2 Market Analysis by Type
1.2.1 Dapagliflozin
1.2.2 Canagliflozin
1.2.3 Empagliflozin
1.2.4 Other
1.3 Market Analysis by Applications
1.3.1 Hospital Pharmacies
1.3.2 Retail Pharmacies
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Eli Lilly
2.1.1 Business Overview
2.1.2 SGLT2 Inhibitor Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Eli Lilly SGLT2 Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Boehringer Ingelheim
2.2.1 Business Overview
2.2.2 SGLT2 Inhibitor Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Boehringer Ingelheim SGLT2 Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Johnson & Johnson
2.3.1 Business Overview
2.3.2 SGLT2 Inhibitor Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Johnson & Johnson SGLT2 Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 AstraZeneca
2.4.1 Business Overview
2.4.2 SGLT2 Inhibitor Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 AstraZeneca SGLT2 Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Merck
2.5.1 Business Overview
2.5.2 SGLT2 Inhibitor Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Merck SGLT2 Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Pfizer
2.6.1 Business Overview
2.6.2 SGLT2 Inhibitor Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Pfizer SGLT2 Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global SGLT2 Inhibitor Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global SGLT2 Inhibitor Sales and Market Share by Manufacturer (2017-2018)
3.2 Global SGLT2 Inhibitor Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 SGLT2 Inhibitor Manufacturer Market Share in 2018
3.3.2 Top 6 SGLT2 Inhibitor Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global SGLT2 Inhibitor Market Analysis by Regions
4.1 Global SGLT2 Inhibitor Sales, Revenue and Market Share by Regions
4.1.1 Global SGLT2 Inhibitor Sales and Market Share by Regions (2014-2019)
4.1.2 Global SGLT2 Inhibitor Revenue and Market Share by Regions (2014-2019)
4.2 North America SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
4.3 Europe SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
4.5 South America SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
5 North America SGLT2 Inhibitor by Country
5.1 North America SGLT2 Inhibitor Sales, Revenue and Market Share by Country
5.1.1 North America SGLT2 Inhibitor Sales and Market Share by Country (2014-2019)
5.1.2 North America SGLT2 Inhibitor Revenue and Market Share by Country (2014-2019)
5.2 United States SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
5.3 Canada SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
5.4 Mexico SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
6 Europe SGLT2 Inhibitor by Country
6.1 Europe SGLT2 Inhibitor Sales, Revenue and Market Share by Country
6.1.1 Europe SGLT2 Inhibitor Sales and Market Share by Country (2014-2019)
6.1.2 Europe SGLT2 Inhibitor Revenue and Market Share by Country (2014-2019)
6.2 Germany SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
6.3 UK SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
6.4 France SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
6.5 Russia SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
6.6 Italy SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
7 Asia-Pacific SGLT2 Inhibitor by Country
7.1 Asia-Pacific SGLT2 Inhibitor Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific SGLT2 Inhibitor Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific SGLT2 Inhibitor Revenue and Market Share by Country (2014-2019)
7.2 China SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
7.3 Japan SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
7.4 Korea SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
7.5 India SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
7.6 Southeast Asia SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
8 South America SGLT2 Inhibitor by Country
8.1 South America SGLT2 Inhibitor Sales, Revenue and Market Share by Country
8.1.1 South America SGLT2 Inhibitor Sales and Market Share by Country (2014-2019)
8.1.2 South America SGLT2 Inhibitor Revenue and Market Share by Country (2014-2019)
8.2 Brazil SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
8.3 Argentina SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
8.4 Colombia SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
9 Middle East and Africa SGLT2 Inhibitor by Countries
9.1 Middle East and Africa SGLT2 Inhibitor Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa SGLT2 Inhibitor Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa SGLT2 Inhibitor Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
9.3 Turkey SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
9.4 Egypt SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
9.5 Nigeria SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
9.6 South Africa SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
10 Global SGLT2 Inhibitor Market Segment by Type
10.1 Global SGLT2 Inhibitor Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global SGLT2 Inhibitor Sales and Market Share by Type (2014-2019)
10.1.2 Global SGLT2 Inhibitor Revenue and Market Share by Type (2014-2019)
10.2 Dapagliflozin Sales Growth and Price
10.2.1 Global Dapagliflozin Sales Growth (2014-2019)
10.2.2 Global Dapagliflozin Price (2014-2019)
10.3 Canagliflozin Sales Growth and Price
10.3.1 Global Canagliflozin Sales Growth (2014-2019)
10.3.2 Global Canagliflozin Price (2014-2019)
10.4 Empagliflozin Sales Growth and Price
10.4.1 Global Empagliflozin Sales Growth (2014-2019)
10.4.2 Global Empagliflozin Price (2014-2019)
10.5 Other Sales Growth and Price
10.5.1 Global Other Sales Growth (2014-2019)
10.5.2 Global Other Price (2014-2019)
11 Global SGLT2 Inhibitor Market Segment by Application
11.1 Global SGLT2 Inhibitor Sales Market Share by Application (2014-2019)
11.2 Hospital Pharmacies Sales Growth (2014-2019)
11.3 Retail Pharmacies Sales Growth (2014-2019)
12 SGLT2 Inhibitor Market Forecast (2019-2024)
12.1 Global SGLT2 Inhibitor Sales, Revenue and Growth Rate (2019-2024)
12.2 SGLT2 Inhibitor Market Forecast by Regions (2019-2024)
12.2.1 North America SGLT2 Inhibitor Market Forecast (2019-2024)
12.2.2 Europe SGLT2 Inhibitor Market Forecast (2019-2024)
12.2.3 Asia-Pacific SGLT2 Inhibitor Market Forecast (2019-2024)
12.2.4 South America SGLT2 Inhibitor Market Forecast (2019-2024)
12.2.5 Middle East and Africa SGLT2 Inhibitor Market Forecast (2019-2024)
12.3 SGLT2 Inhibitor Market Forecast by Type (2019-2024)
12.3.1 Global SGLT2 Inhibitor Sales Forecast by Type (2019-2024)
12.3.2 Global SGLT2 Inhibitor Market Share Forecast by Type (2019-2024)
12.4 SGLT2 Inhibitor Market Forecast by Application (2019-2024)
12.4.1 Global SGLT2 Inhibitor Sales Forecast by Application (2019-2024)
12.4.2 Global SGLT2 Inhibitor Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure SGLT2 Inhibitor Picture
Table Product Specifications of SGLT2 Inhibitor
Figure Global Sales Market Share of SGLT2 Inhibitor by Types in 2018
Table SGLT2 Inhibitor Types for Major Manufacturers
Figure Dapagliflozin Picture
Figure Canagliflozin Picture
Figure Empagliflozin Picture
Figure Other Picture
Figure SGLT2 Inhibitor Sales Market Share by Applications in 2018
Figure Hospital Pharmacies Picture
Figure Retail Pharmacies Picture
Figure United States SGLT2 Inhibitor Revenue (Value) and Growth Rate (2014-2024)
Figure Canada SGLT2 Inhibitor Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico SGLT2 Inhibitor Revenue (Value) and Growth Rate (2014-2024)
Figure Germany SGLT2 Inhibitor Revenue (Value) and Growth Rate (2014-2024)
Figure France SGLT2 Inhibitor Revenue (Value) and Growth Rate (2014-2024)
Figure UK SGLT2 Inhibitor Revenue (Value) and Growth Rate (2014-2024)
Figure Russia SGLT2 Inhibitor Revenue (Value) and Growth Rate (2014-2024)
Figure Italy SGLT2 Inhibitor Revenue (Value) and Growth Rate (2014-2024)
Figure China SGLT2 Inhibitor Revenue (Value) and Growth Rate (2014-2024)
Figure Japan SGLT2 Inhibitor Revenue (Value) and Growth Rate (2014-2024)
Figure Korea SGLT2 Inhibitor Revenue (Value) and Growth Rate (2014-2024)
Figure India SGLT2 Inhibitor Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia SGLT2 Inhibitor Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil SGLT2 Inhibitor Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt SGLT2 Inhibitor Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia SGLT2 Inhibitor Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa SGLT2 Inhibitor Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria SGLT2 Inhibitor Revenue (Value) and Growth Rate (2014-2024)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly SGLT2 Inhibitor Type and Applications
Table Eli Lilly SGLT2 Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim SGLT2 Inhibitor Type and Applications
Table Boehringer Ingelheim SGLT2 Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson SGLT2 Inhibitor Type and Applications
Table Johnson & Johnson SGLT2 Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca SGLT2 Inhibitor Type and Applications
Table AstraZeneca SGLT2 Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck SGLT2 Inhibitor Type and Applications
Table Merck SGLT2 Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer SGLT2 Inhibitor Type and Applications
Table Pfizer SGLT2 Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global SGLT2 Inhibitor Sales by Manufacturer (2017-2018)
Figure Global SGLT2 Inhibitor Sales Market Share by Manufacturer in 2017
Figure Global SGLT2 Inhibitor Sales Market Share by Manufacturer in 2018
Table Global SGLT2 Inhibitor Revenue by Manufacturer (2017-2018)
Figure Global SGLT2 Inhibitor Revenue Market Share by Manufacturer in 2017
Figure Global SGLT2 Inhibitor Revenue Market Share by Manufacturer in 2018
Figure Top 3 SGLT2 Inhibitor Manufacturer (Revenue) Market Share in 2018
Figure Top 6 SGLT2 Inhibitor Manufacturer (Revenue) Market Share in 2018
Figure Global SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
Figure Global SGLT2 Inhibitor Revenue and Growth Rate (2014-2019)
Table Global SGLT2 Inhibitor Sales by Regions (2014-2019)
Table Global SGLT2 Inhibitor Sales Market Share by Regions (2014-2019)
Table Global SGLT2 Inhibitor Revenue by Regions (2014-2019)
Figure Global SGLT2 Inhibitor Revenue Market Share by Regions in 2014
Figure Global SGLT2 Inhibitor Revenue Market Share by Regions in 2018
Figure North America SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
Figure Europe SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
Figure Asia-Pacific SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
Figure South America SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
Figure Middle East and Africa SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
Figure North America SGLT2 Inhibitor Revenue and Growth Rate (2014-2019)
Table North America SGLT2 Inhibitor Sales by Countries (2014-2019)
Table North America SGLT2 Inhibitor Sales Market Share by Countries (2014-2019)
Figure North America SGLT2 Inhibitor Sales Market Share by Countries in 2014
Figure North America SGLT2 Inhibitor Sales Market Share by Countries in 2018
Table North America SGLT2 Inhibitor Revenue by Countries (2014-2019)
Table North America SGLT2 Inhibitor Revenue Market Share by Countries (2014-2019)
Figure North America SGLT2 Inhibitor Revenue Market Share by Countries in 2014
Figure North America SGLT2 Inhibitor Revenue Market Share by Countries in 2018
Figure United States SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
Figure Canada SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
Figure Mexico SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
Figure Europe SGLT2 Inhibitor Revenue and Growth Rate (2014-2019)
Table Europe SGLT2 Inhibitor Sales by Countries (2014-2019)
Table Europe SGLT2 Inhibitor Sales Market Share by Countries (2014-2019)
Table Europe SGLT2 Inhibitor Revenue by Countries (2014-2019)
Figure Europe SGLT2 Inhibitor Revenue Market Share by Countries in 2017
Figure Europe SGLT2 Inhibitor Revenue Market Share by Countries in 2018
Figure Germany SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
Figure UK SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
Figure France SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
Figure Russia SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
Figure Italy SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
Figure Asia-Pacific SGLT2 Inhibitor Revenue and Growth Rate (2014-2019)
Table Asia-Pacific SGLT2 Inhibitor Sales by Countries (2014-2019)
Table Asia-Pacific SGLT2 Inhibitor Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific SGLT2 Inhibitor Sales Market Share by Countries 2018
Table Asia-Pacific SGLT2 Inhibitor Revenue by Countries (2014-2019)
Figure Asia-Pacific SGLT2 Inhibitor Revenue Market Share by Countries 2018
Figure China SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
Figure Japan SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
Figure Korea SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
Figure India SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
Figure Southeast Asia SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
Figure South America SGLT2 Inhibitor Revenue and Growth Rate (2014-2019)
Table South America SGLT2 Inhibitor Sales by Countries (2014-2019)
Table South America SGLT2 Inhibitor Sales Market Share by Countries (2014-2019)
Figure South America SGLT2 Inhibitor Sales Market Share by Countries in 2018
Table South America SGLT2 Inhibitor Revenue by Countries (2014-2019)
Table South America SGLT2 Inhibitor Revenue Market Share by Countries (2014-2019)
Figure South America SGLT2 Inhibitor Revenue Market Share by Countries in 2018
Figure Brazil SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
Figure Argentina SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
Figure Colombia SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
Figure Middle East and Africa SGLT2 Inhibitor Revenue and Growth Rate (2014-2019)
Table Middle East and Africa SGLT2 Inhibitor Sales by Countries (2014-2019)
Table Middle East and Africa SGLT2 Inhibitor Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa SGLT2 Inhibitor Sales Market Share by Countries in 2018
Table Middle East and Africa SGLT2 Inhibitor Revenue by Countries (2014-2019)
Table Middle East and Africa SGLT2 Inhibitor Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa SGLT2 Inhibitor Revenue Market Share by Countries in 2014
Figure Middle East and Africa SGLT2 Inhibitor Revenue Market Share by Countries in 2018
Figure Saudi Arabia SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
Figure UAE SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
Figure Egypt SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
Figure Nigeria SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
Figure South Africa SGLT2 Inhibitor Sales and Growth Rate (2014-2019)
Table Global SGLT2 Inhibitor Sales by Type (2014-2019)
Table Global SGLT2 Inhibitor Sales Share by Type (2014-2019)
Table Global SGLT2 Inhibitor Revenue by Type (2014-2019)
Table Global SGLT2 Inhibitor Revenue Share by Type (2014-2019)
Figure Global Dapagliflozin Sales Growth (2014-2019)
Figure Global Dapagliflozin Price (2014-2019)
Figure Global Canagliflozin Sales Growth (2014-2019)
Figure Global Canagliflozin Price (2014-2019)
Figure Global Empagliflozin Sales Growth (2014-2019)
Figure Global Empagliflozin Price (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Other Price (2014-2019)
Table Global SGLT2 Inhibitor Sales by Application (2014-2019)
Table Global SGLT2 Inhibitor Sales Share by Application (2014-2019)
Figure Global Retail Pharmacies Sales Growth (2014-2019)
Figure Global SGLT2 Inhibitor Sales, Revenue and Growth Rate (2019-2024)
Table Global SGLT2 Inhibitor Sales Forecast by Regions (2019-2024)
Table Global SGLT2 Inhibitor Market Share Forecast by Regions (2019-2024)
Figure North America Sales SGLT2 Inhibitor Market Forecast (2019-2024)
Figure Europe Sales SGLT2 Inhibitor Market Forecast (2019-2024)
Figure Asia-Pacific Sales SGLT2 Inhibitor Market Forecast (2019-2024)
Figure South America Sales SGLT2 Inhibitor Market Forecast (2019-2024)
Figure Middle East and Africa Sales SGLT2 Inhibitor Market Forecast (2019-2024)
Table Global SGLT2 Inhibitor Sales Forecast by Type (2019-2024)
Table Global SGLT2 Inhibitor Market Share Forecast by Type (2019-2024)
Table Global SGLT2 Inhibitor Sales Forecast by Application (2019-2024)
Table Global SGLT2 Inhibitor Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List


【掲載企業】

Eli Lilly、Boehringer Ingelheim、Johnson & Johnson、AstraZeneca、Merck、Pfizer、

★調査レポート[SGLT2阻害剤の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）] (コード：GIR9101275)販売に関する免責事項を必ずご確認ください。
★調査レポート[SGLT2阻害剤の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 膠芽腫治療薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9100019 / GlobalInfoResearch / 2019年10月9日 / 本調査レポートは、膠芽腫治療薬の世界市場について調べ、まとめました。種類別セグメントは、VEGF / VEGFR阻害剤、アルキル化剤、その他の抗腫瘍薬等、用途別セグメントは、病院、がん研究機構、長期介護センター、診断センター等に区分しました。膠芽腫治療薬の世界市場概観、メーカー動向、メーカー別膠芽腫治療薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・膠芽腫治療薬の市場概観 ・膠芽腫治療薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・膠芽腫治療薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・膠芽腫治療薬の世界市場規模 ・膠芽腫治療薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・膠芽腫治療薬のアメリカ市場規模推移 ・膠芽腫治療薬のカナダ市場規模推移... Scope of the Report: The worldwide market for Glioblastoma Treatment Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Glioblastoma Treatment Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Sigma-Tau Pharmaceuticals F. Hoffmann-La Roche AG Bristol-Myers Squibb...
  • 高血圧薬の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101665 / GlobalInfoResearch / 2019年9月12日 / 本調査レポートは、高血圧薬の世界市場について調べ、まとめました。種類別セグメントは、利尿降圧薬、交感神経抑制薬、レニン-アンジオテンシン系阻害薬、カルシウム拮抗薬、血管拡張薬等、用途別セグメントは、老人、妊婦、一般患者等に区分しました。高血圧薬の世界市場概観、メーカー動向、メーカー別高血圧薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・高血圧薬の市場概観 ・高血圧薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・高血圧薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・高血圧薬の世界市場規模 ・高血圧薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・高血圧薬のアメリカ市場規模推移 ・高血圧薬のカナダ市場規模推移 ・高血圧薬のメキシコ市場規模推移 ・高血圧薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Antihypertensive drug is a kind of medicine that can control blood pressure and is used to treat hypertension. Scope of the Report: The worldwide market for Antihypertensive Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Antihypertensive Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application....
  • オンカスパーの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103623 / GlobalInfoResearch / 2019年9月27日 / 本調査レポートは、オンカスパーの世界市場について調べ、まとめました。種類別セグメントは、凍結乾燥したオンカスパー、液体のオンカスパー等、用途別セグメントは、大病院、中小病院等に区分しました。オンカスパーの世界市場概観、メーカー動向、メーカー別オンカスパーシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・オンカスパーの市場概観 ・オンカスパーの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・オンカスパーの企業別販売動向、市場シェア、市場集中度、競争動向 ・オンカスパーの世界市場規模 ・オンカスパーの北米市場分析（アメリカ、カナダ、メキシコ等） ・オンカスパーのアメリカ市場規模推移 ・オンカスパーのカナダ市場規模推移 ・オンカスパーのメキシコ市場規模推移 ・オンカスパーのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Description Scope of the Report: The worldwide market for Oncaspar is expected to grow at a CAGR of roughly 10.9% over the next five years, will reach 290.5 million US$ in 2024, from 192.2 million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Oncaspar in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Servier Market Segment by Regions, regional analysis covers North America (United States,...

    • ◆H&Iグローバルリサーチのお客様（例）◆